Semler Scientific, Inc. (NASDAQ:SMLR – Get Free Report) was the recipient of a significant growth in short interest during the month of November. As of November 30th, there was short interest totalling 1,280,000 shares, a growth of 43.4% from the November 15th total of 892,400 shares. Approximately 20.4% of the shares of the stock are sold short. Based on an average daily volume of 485,000 shares, the days-to-cover ratio is presently 2.6 days.
Hedge Funds Weigh In On Semler Scientific
Several hedge funds and other institutional investors have recently modified their holdings of the stock. CWM LLC raised its position in Semler Scientific by 486.3% during the second quarter. CWM LLC now owns 897 shares of the company’s stock valued at $31,000 after acquiring an additional 744 shares in the last quarter. Newbridge Financial Services Group Inc. acquired a new stake in shares of Semler Scientific in the second quarter worth approximately $34,000. Quest Partners LLC purchased a new stake in shares of Semler Scientific during the second quarter worth $59,000. Meeder Asset Management Inc. purchased a new stake in Semler Scientific during the 2nd quarter valued at about $67,000. Finally, US Bancorp DE increased its stake in shares of Semler Scientific by 60.8% in the 3rd quarter. US Bancorp DE now owns 3,064 shares of the company’s stock worth $72,000 after acquiring an additional 1,158 shares during the last quarter. 49.37% of the stock is owned by hedge funds and other institutional investors.
Semler Scientific Trading Down 6.5 %
NASDAQ:SMLR traded down $4.67 during midday trading on Friday, hitting $67.17. 971,401 shares of the company traded hands, compared to its average volume of 1,077,116. Semler Scientific has a 12-month low of $20.88 and a 12-month high of $79.45. The firm has a market capitalization of $556.84 million, a P/E ratio of 32.77 and a beta of 1.18. The firm’s fifty day moving average is $43.82 and its 200-day moving average is $34.79.
About Semler Scientific
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.
Read More
- Five stocks we like better than Semler Scientific
- The Basics of Support and Resistance
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.